Supplementary Figure 3 from Regulation of CD4&lt;sup&gt;+&lt;/sup&gt;NKG2D&lt;sup&gt;+&lt;/sup&gt; Th1 Cells in Patients with Metastatic Melanoma Treated with Sorafenib: Role of IL-15Rα and NKG2D Triggering